Clinical Trial Update: Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the safety and efficacy of delivering high-dose melphalan directly into the liver, followed by an approved cancer treatme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Alkeran (melphalan)

Snippet

Sponsor: Delcath Systems Inc. | Conditions: Metastatic Breast Cancer in the Liver | Phase 2 | Status: RECRUITING